All You Need to Know About Ermenegildo Zegna (ZGN) Rating Upgrade to Buy — Positive
ZGN Zacks Investment Research — June 25, 2025Ermenegildo Zegna (ZGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Betterware de Mexico SAPI de C (BWMX) Upgraded to Strong Buy: Here's What You Should Know — Positive
BWMX Zacks Investment Research — June 25, 2025Betterware de Mexico SAPI de C (BWMX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
What Makes Veeva (VEEV) a New Strong Buy Stock — Positive
VEEV Zacks Investment Research — June 25, 2025Veeva (VEEV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
CVB Financial (CVBF) Upgraded to Buy: Here's What You Should Know — Positive
CVBF Zacks Investment Research — June 25, 2025CVB Financial (CVBF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
BioCryst (BCRX) Upgraded to Strong Buy: What Does It Mean for the Stock? — Positive
BCRX Zacks Investment Research — June 25, 2025BioCryst (BCRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Hilltop Holdings (HTH) Upgraded to Buy: Here's What You Should Know — Positive
HTH Zacks Investment Research — June 25, 2025Hilltop Holdings (HTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Candel Therapeutics (CADL) Upgraded to Strong Buy: Here's What You Should Know — Positive
CADL Zacks Investment Research — June 25, 2025Candel Therapeutics (CADL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
All You Need to Know About ResMed (RMD) Rating Upgrade to Buy — Positive
RMD Zacks Investment Research — June 25, 2025ResMed (RMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Solaris Energy Infrastructure, Inc. (SEI) Upgraded to Buy: Here's What You Should Know — Positive
SEI Zacks Investment Research — June 25, 2025Solaris Energy Infrastructure, Inc. (SEI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here's Why Manchester United (MANU) is a Great Momentum Stock to Buy — Positive
MANU Zacks Investment Research — June 25, 2025Does Manchester United (MANU) have what it takes to be a top stock pick for momentum investors? Let's find out.
Ferguson plc (FERG) is a Great Momentum Stock: Should You Buy? — Positive
FERG Zacks Investment Research — June 25, 2025Does Ferguson plc (FERG) have what it takes to be a top stock pick for momentum investors? Let's find out.
Evercore (EVR) is a Great Momentum Stock: Should You Buy? — Positive
EVR Zacks Investment Research — June 25, 2025Does Evercore (EVR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Inter & Co. Inc. (INTR) is a Great Momentum Stock: Should You Buy? — Positive
INTR Zacks Investment Research — June 25, 2025Does Inter & Co. Inc. (INTR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Sterling Infrastructure (STRL) is a Great Momentum Stock: Should You Buy? — Positive
STRL Zacks Investment Research — June 25, 2025Does Sterling Infrastructure (STRL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Allegro MicroSystems, Inc. (ALGM) Is Up 8.06% in One Week: What You Should Know — Positive
ALGM Zacks Investment Research — June 25, 2025Does Allegro MicroSystems, Inc. (ALGM) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are You Looking for a Top Momentum Pick? Why Alamo Group (ALG) is a Great Choice — Positive
ALG Zacks Investment Research — June 25, 2025Does Alamo Group (ALG) have what it takes to be a top stock pick for momentum investors? Let's find out.
What's Going On With Viking Therapeutics Stock On Wednesday? — Positive
VKTX Benzinga — June 25, 2025Viking Therapeutics, Inc. VKTX on Wednesday initiated the VANQUISH Phase 3 clinical program for VK2735, the company's dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.
Energy Transfer: For Those Tired Of The Oil Price Rollercoaster — Negative
ET Seeking Alpha — June 25, 2025Oil prices are likely to remain highly volatile given the undergoing geopolitical risks, especially the OPEC+ production decisions and also the Israel-Iran conflict. ET can help shield energy investors against oil price fluctuations due to its fee-based model, consistent dividends, and generous yield. In addition, the use of P/E ratios exaggerates its valuation, which is quite reasonable when adjusted for leverages.
Compass Group Diversified Holdings (CODI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
CODI PRNewsWire — June 25, 2025LOS ANGELES , June 25, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Compass Group Diversified Holdings ("Compass" or the "Company") (NYSE: CODI). IF YOU SUFFERED A LOSS ON YOUR COMPASS INVESTMENTS, CLICK HERE BEFORE JULY 8, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
WST PRNewsWire — June 25, 2025LOS ANGELES , June 25, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST). IF YOU SUFFERED A LOSS ON YOUR WEST INVESTMENTS, CLICK HERE BEFORE JULY 7, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
